MedPath

Type 1 Diabetes Data Acquisition and Transfer Adherence Study

Phase 1
Completed
Conditions
Type 1 Diabetes Mellitus
Registration Number
NCT03228004
Lead Sponsor
University of Florida
Brief Summary

The purpose of this pilot study is to determine if training and support, combined with reminders to facilitate glucose data sharing with the diabetes care team in between clinic visits, can improve glycemic outcomes for patients ages 10-17 with type 1 diabetes who have HbA1c levels above target.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
53
Inclusion Criteria
  • Diagnosis with T1D at least 6 months before consent is obtained
  • Aged ≥ 2 years and ≤17 years at time of enrollment
  • Must have access to a smartphone, tablet or computer at home with wireless connectivity
  • Last HbA1c of ≥7.6% and ≤11%
  • Using fixed doses, multiple daily injections or an insulin pump as primary diabetes management regimen
  • Ability to read and speak English
  • Patient at UF Health Pediatric Diabetes Clinic
Exclusion Criteria
  • Significant medical comorbidity in the child or adolescent that could, in the opinion of the PI, affect participant's capacity to complete study follow up
  • Inability to read and speak English
  • Not using insulin therapy
  • Lack of access to mobile device or computer with wireless internet connectivity
  • Unwilling or unable to use clinic's software (Glooko) to facilitate glucose data upload

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Improved glycemic control16 weeks

HbA1c

Frequency of data upload16 weeks

The number of times glucose data is uploaded between clinic visits

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Florida

🇺🇸

Gainesville, Florida, United States

University of Florida
🇺🇸Gainesville, Florida, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.